Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy Systematic Findings and Risk Stratification by OCT

Cardiovascular Aspects of Radiolog

Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study

Objectives We aimed to evaluate the mechanical properties and healing patterns 6 and 9 months after implantation of the sirolimus-eluting Fantom bioresorbable scaffold (BRS). Background The Fantom BRS (Reva Medical, San Diego, USA) has differentiating properties including radiopacity, strut thickness of 125 µm, high expansion capacity and has demonstrated favourable mid-term clinical and angiographic outcomes. Methods and results FANTOM II was a prospective, single arm study with implantation of the Fantom BRS in 240 patients with stable angina pectoris. Guidance by optical coherence tomography (OCT) was encouraged and was repeated at 6-month (cohort A) or 9-month follow-up (cohort B). Matched baseline and follow-up OCT recordings were available in 152 patients. In-scaffold mean lumen area in cohort A was 6.8±1.7mm2 and 5.7±1.4mm2 at baseline and follow-up (p<0.0001) and was 7.2±1.6mm2 and 5.6±1.4mm2 in cohort B (p<0.0001). Mean scaffold area remained stable from 7.1±1.5mm2 at baseline to 7.2±1.4mm2 at 6 months (p=0.12), and from 7.4±1.5mm2 to 7.3±1.4mm2 at 9 months. Strut malapposition was median 0.8 (IQR 0.0;3.5)% and 1.8 (IQR 0.3;6.0)% at baseline and was 0.0 (IQR 0.0;0.0)% in both groups at 6-month and 9-month follow-up. Strut tissue coverage was 98.1 (IQR 95.9;99.4)% at 6 months and 98.9 (IQR 98.3;100.0)% at 9 months. Conclusions The novel Fantom BRS had favourable healing patterns at 6-month and 9-month follow-up as malapposition was effectively resolved and strut coverage was almost complete. The scaffold remained stable through follow-up with no signs of systematic late recoil

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies

Objectives: The purpose of this document is to make the output of the International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT) Standardization and Validation available to medical and scientific communities, through a peer-reviewed publication, in the interest of improving the diagnosis and treatment of patients with atherosclerosis, including coronary artery disease. Background: Intravascular optical coherence tomography (IVOCT) is a catheter-based modality that acquires images at a resolution of ∼10 μm, enabling visualization of blood vessel wall microstructure in vivo at an unprecedented level of detail. IVOCT devices are now commercially available worldwide, there is an active user base, and the interest in using this technology is growing. Incorporation of IVOCT in research and daily clinical practice can be facilitated by the development of uniform terminology and consensus-based standards on use of the technology, interpretation of the images, and reporting of IVOCT results. Methods: The IWG-IVOCT, comprising more than 260 academic and industry members from Asia, Europe, and the United States, formed in 2008 and convened on the topic of IVOCT standardization through a series of 9 national and international meetings. Results: Knowledge and recommendations from this group on key areas within the IVOCT field were assembled to generate this consensus document, authored by the Writing Committee, composed of academicians who have participated in meetings and/or writing of the text. Conclusions: This document may be broadly used as a standard reference regarding the current state of the IVOCT imaging modality, intended for researchers and clinicians who use IVOCT and analyze IVOCT data

Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction

The electrocardiographic PR interval reflects atrioventricular conduction, and is associated with conduction abnormalities, pacemaker implantation, atrial fibrillation (AF), and cardiovascular mortality. Here we report a multi-ancestry (N = 293,051) genome-wide association meta-analysis for the PR interval, discovering 202 loci of which 141 have not previously been reported. Variants at identified loci increase the percentage of heritability explained, from 33.5% to 62.6%. We observe enrichment for cardiac muscle developmental/contractile and cytoskeletal genes, highlighting key regulation processes for atrioventricular conduction. Additionally, 8 loci not previously reported harbor genes underlying inherited arrhythmic syndromes and/or cardiomyopathies suggesting a role for these genes in cardiovascular pathology in the general population. We show that polygenic predisposition to PR interval duration is an endophenotype for cardiovascular disease, including distal conduction disease, AF, and atrioventricular pre-excitation. These findings advance our understanding of the polygenic basis of cardiac conduction, and the genetic relationship between PR interval duration and cardiovascular disease

Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits : A Multi-Ethnic Meta-Analysis of 45,891 Individuals

J. Kaprio, S. Ripatti ja M.-L. Lokki työryhmien jäseniä.Peer reviewe

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

BACKGROUND: Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. METHODS: The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk–outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. FINDINGS: Globally, in 2019, the risk factors included in this analysis accounted for 4·45 million (95% uncertainty interval 4·01–4·94) deaths and 105 million (95·0–116) DALYs for both sexes combined, representing 44·4% (41·3–48·4) of all cancer deaths and 42·0% (39·1–45·6) of all DALYs. There were 2·88 million (2·60–3·18) risk-attributable cancer deaths in males (50·6% [47·8–54·1] of all male cancer deaths) and 1·58 million (1·36–1·84) risk-attributable cancer deaths in females (36·3% [32·5–41·3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20·4% (12·6–28·4) and DALYs by 16·8% (8·8–25·0), with the greatest percentage increase in metabolic risks (34·7% [27·9–42·8] and 33·3% [25·8–42·0]). INTERPRETATION: The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden

First Presentation of 3-Dimensional Reconstruction and Centerline-Guided Assessment of Coronary Bifurcation by Fusion of X-Ray Angiography and Optical Coherence Tomography

Cardiovascular Aspects of Radiolog

PREDICTORS OF STENT ECCENTRICITY AFTER IMPLANTATION OF A NOVOLIMUS ELUTING BIORESORBABLE STENT IN CORONARY BIFURCATIONS

Cardiovascular Aspects of Radiolog

The Impact of Acquisition Angle Differences on Three-Dimensional Quantitative Coronary Angiography

Background: Three-dimensional (3D) quantitative coronary angiography (QCA) requires two angiographic views to restore vessel dimensions. This study investigated the impact of acquisition angle differences (AADs) of the two angiographic views on the assessed dimensions by 3D QCA. Methods: X-ray angiograms of an assembled brass phantom with different types of straight lesions were recorded at multiple angiographic projections. The projections were randomly matched as pairs and 3D QCA was performed in those pairs with AAD larger than 25 degrees. The lesion length and diameter stenosis in three different lesions, a circular concentric severe lesion (A), a circular concentric moderate lesion (B), and a circular eccentric moderate lesion (C), were measured by 3D QCA. The acquisition protocol was repeated for a silicone bifurcation phantom, and the bifurcation angles and bifurcation core volume were measured by 3D QCA. The measurements were compared with the true dimensions if applicable and their correlation with AAD was studied. Results: 50 matched pairs of angiographic views were analyzed for the brass phantom. The average value of AAD was 48.0 +/- 14.1 degrees. The percent diameter stenosis was slightly overestimated by 3D QCA for all lesions: A (error 1.2 +/- 0.9%, P < 0.001); B (error 0.6 +/- 0.5%, P < 0.001); C (error 1.1 +/- 0.6%, P < 0.001). The correlation of the measurements with AAD was only significant for lesion A (R-2 = 0.151, P = 0.005). The lesion length was slightly overestimated by 3D QCA for lesion A (error 0.06 +/- 0.18 mm, P = 0.026), but well assessed for lesion B (error -0.00 +/- 0.16 mm, P = 0.950) and lesion C (error -0.01 +/- 0.18 mm, P = 0.585). The correlation of the measurements with AAD was not significant for any lesion. Forty matched pairs of angiographic views were analyzed for the bifurcation phantom. The average value of AAD was 49.1 +/- 15.4 degrees. 3D QCA slightly overestimated the proximal angle (error 0.4 +/- 1.1 degrees, P = 0.046) and the distal angle (error 1.5 +/- 1.3 degrees, P < 0.001). The correlation with AAD was only significant for the distal angle (R-2 = 0.256, P = 0.001). The correlation of bifurcation core volume measurements with AAD was not significant (P = 0.750). Of the two aforementioned measurements with significant correlation with AAD, the errors tended to increase as AAD became larger. Conclusions: 3D QCA can be used to reliably assess vessel dimensions and bifurcation angles. Increasing the AAD of the two angiographic views does not increase accuracy and precision of 3D QCA for circular lesions or bifurcation dimensions. (C) 2011 Wiley-Liss, Inc